Click for best price
Biomarker Testing for Cancer Market Size, Share 2022
Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells.
This report contains market size and forecasts of Biomarker Testing for Cancer in global, including the following market information:
The global Biomarker Testing for Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Protein Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biomarker Testing for Cancer include F. Hoffmann-L A Roche, Thermo Fisher Scientific, Qiagen N.V., Bio-Rad L aboratories and llumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Biomarker Testing for Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biomarker Testing for Cancer Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Type, 2021 (%)
- Protein Biomarkers
- Genetic Biomarkers
- Others
Global Biomarker Testing for Cancer Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, by Application, 2021 (%)
- Diagnostics
- Research & Development
- Prognostics
- Risk Assessment
- Others
Global Biomarker Testing for Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biomarker Testing for Cancer Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biomarker Testing for Cancer revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Biomarker Testing for Cancer revenues share in global market, 2021 (%)
- Key companies Biomarker Testing for Cancer sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Biomarker Testing for Cancer sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F. Hoffmann-L A Roche
- Thermo Fisher Scientific
- Qiagen N.V.
- Bio-Rad L aboratories
- llumina
| Report Attributes |
Report Details |
| Report Title |
Biomarker Testing for Cancer Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biomarker Testing for Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biomarker Testing for Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biomarker Testing for Cancer Overall Market Size
2.1 Global Biomarker Testing for Cancer Market Size: 2021 VS 2028
2.2 Global Biomarker Testing for Cancer Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biomarker Testing for Cancer Sales: 2017-2028
3 Company Landscape
3.1 Top Biomarker Testing for Cancer Players in Global Market
3.2 Top Global Biomarker Testing for Cancer Companies Ranked by Revenue
3.3 Global Biomarker Testing for Cancer Revenue by Companies
3.4 Global Biomarker Testing for Cancer Sales by Companies
3.5 Global Biomarker Testing for Cancer Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biomarker Testing for Cancer Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biomarker Testing for Cancer Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biomarker Testing for Cancer Players in Global Market
3.8.1 List of Global Tier 1 Biomarker Testing for Cancer Companies
3.8.2 List of Global Tier 2 and Tier 3 Biomarker Testing for Cancer Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biomarker Testing for Cancer Market Size Markets, 2021 & 2028
4.1.2 Protein Biomarkers
4.1.3 Genetic Biomarkers
4.1.4 Others
4.2 By Type - Global Biomarker Testing for Cancer Revenue & Forecasts
4.2.1 By Type - Global Biomarker Testing for Cancer Revenue, 2017-2022
4.2.2 By Type - Global Biomarker Testing for Cancer Revenue, 2023-2028
4.2.3 By Type - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
4.3 By Type - Global Biomarker Testing for Cancer Sales & Forecasts
4.3.1 By Type - Global Biomarker Testing for Cancer Sales, 2017-2022
4.3.2 By Type - Global Biomarker Testing for Cancer Sales, 2023-2028
4.3.3 By Type - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
4.4 By Type - Global Biomarker Testing for Cancer Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Biomarker Testing for Cancer Market Size, 2021 & 2028
5.1.2 Diagnostics
5.1.3 Research & Development
5.1.4 Prognostics
5.1.5 Risk Assessment
5.1.6 Others
5.2 By Application - Global Biomarker Testing for Cancer Revenue & Forecasts
5.2.1 By Application - Global Biomarker Testing for Cancer Revenue, 2017-2022
5.2.2 By Application - Global Biomarker Testing for Cancer Revenue, 2023-2028
5.2.3 By Application - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
5.3 By Application - Global Biomarker Testing for Cancer Sales & Forecasts
5.3.1 By Application - Global Biomarker Testing for Cancer Sales, 2017-2022
5.3.2 By Application - Global Biomarker Testing for Cancer Sales, 2023-2028
5.3.3 By Application - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
5.4 By Application - Global Biomarker Testing for Cancer Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biomarker Testing for Cancer Market Size, 2021 & 2028
6.2 By Region - Global Biomarker Testing for Cancer Revenue & Forecasts
6.2.1 By Region - Global Biomarker Testing for Cancer Revenue, 2017-2022
6.2.2 By Region - Global Biomarker Testing for Cancer Revenue, 2023-2028
6.2.3 By Region - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
6.3 By Region - Global Biomarker Testing for Cancer Sales & Forecasts
6.3.1 By Region - Global Biomarker Testing for Cancer Sales, 2017-2022
6.3.2 By Region - Global Biomarker Testing for Cancer Sales, 2023-2028
6.3.3 By Region - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biomarker Testing for Cancer Revenue, 2017-2028
6.4.2 By Country - North America Biomarker Testing for Cancer Sales, 2017-2028
6.4.3 US Biomarker Testing for Cancer Market Size, 2017-2028
6.4.4 Canada Biomarker Testing for Cancer Market Size, 2017-2028
6.4.5 Mexico Biomarker Testing for Cancer Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biomarker Testing for Cancer Revenue, 2017-2028
6.5.2 By Country - Europe Biomarker Testing for Cancer Sales, 2017-2028
6.5.3 Germany Biomarker Testing for Cancer Market Size, 2017-2028
6.5.4 France Biomarker Testing for Cancer Market Size, 2017-2028
6.5.5 U.K. Biomarker Testing for Cancer Market Size, 2017-2028
6.5.6 Italy Biomarker Testing for Cancer Market Size, 2017-2028
6.5.7 Russia Biomarker Testing for Cancer Market Size, 2017-2028
6.5.8 Nordic Countries Biomarker Testing for Cancer Market Size, 2017-2028
6.5.9 Benelux Biomarker Testing for Cancer Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biomarker Testing for Cancer Revenue, 2017-2028
6.6.2 By Region - Asia Biomarker Testing for Cancer Sales, 2017-2028
6.6.3 China Biomarker Testing for Cancer Market Size, 2017-2028
6.6.4 Japan Biomarker Testing for Cancer Market Size, 2017-2028
6.6.5 South Korea Biomarker Testing for Cancer Market Size, 2017-2028
6.6.6 Southeast Asia Biomarker Testing for Cancer Market Size, 2017-2028
6.6.7 India Biomarker Testing for Cancer Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biomarker Testing for Cancer Revenue, 2017-2028
6.7.2 By Country - South America Biomarker Testing for Cancer Sales, 2017-2028
6.7.3 Brazil Biomarker Testing for Cancer Market Size, 2017-2028
6.7.4 Argentina Biomarker Testing for Cancer Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biomarker Testing for Cancer Sales, 2017-2028
6.8.3 Turkey Biomarker Testing for Cancer Market Size, 2017-2028
6.8.4 Israel Biomarker Testing for Cancer Market Size, 2017-2028
6.8.5 Saudi Arabia Biomarker Testing for Cancer Market Size, 2017-2028
6.8.6 UAE Biomarker Testing for Cancer Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-L A Roche
7.1.1 F. Hoffmann-L A Roche Corporate Summary
7.1.2 F. Hoffmann-L A Roche Business Overview
7.1.3 F. Hoffmann-L A Roche Biomarker Testing for Cancer Major Product Offerings
7.1.4 F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
7.1.5 F. Hoffmann-L A Roche Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Biomarker Testing for Cancer Major Product Offerings
7.2.4 Thermo Fisher Scientific Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
7.2.5 Thermo Fisher Scientific Key News
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Corporate Summary
7.3.2 Qiagen N.V. Business Overview
7.3.3 Qiagen N.V. Biomarker Testing for Cancer Major Product Offerings
7.3.4 Qiagen N.V. Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
7.3.5 Qiagen N.V. Key News
7.4 Bio-Rad L aboratories
7.4.1 Bio-Rad L aboratories Corporate Summary
7.4.2 Bio-Rad L aboratories Business Overview
7.4.3 Bio-Rad L aboratories Biomarker Testing for Cancer Major Product Offerings
7.4.4 Bio-Rad L aboratories Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
7.4.5 Bio-Rad L aboratories Key News
7.5 llumina
7.5.1 llumina Corporate Summary
7.5.2 llumina Business Overview
7.5.3 llumina Biomarker Testing for Cancer Major Product Offerings
7.5.4 llumina Biomarker Testing for Cancer Sales and Revenue in Global (2017-2022)
7.5.5 llumina Key News
8 Global Biomarker Testing for Cancer Production Capacity, Analysis
8.1 Global Biomarker Testing for Cancer Production Capacity, 2017-2028
8.2 Biomarker Testing for Cancer Production Capacity of Key Manufacturers in Global Market
8.3 Global Biomarker Testing for Cancer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biomarker Testing for Cancer Supply Chain Analysis
10.1 Biomarker Testing for Cancer Industry Value Chain
10.2 Biomarker Testing for Cancer Upstream Market
10.3 Biomarker Testing for Cancer Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biomarker Testing for Cancer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biomarker Testing for Cancer in Global Market
Table 2. Top Biomarker Testing for Cancer Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biomarker Testing for Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biomarker Testing for Cancer Revenue Share by Companies, 2017-2022
Table 5. Global Biomarker Testing for Cancer Sales by Companies, (K Units), 2017-2022
Table 6. Global Biomarker Testing for Cancer Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biomarker Testing for Cancer Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Biomarker Testing for Cancer Product Type
Table 9. List of Global Tier 1 Biomarker Testing for Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biomarker Testing for Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biomarker Testing for Cancer Sales (K Units), 2017-2022
Table 15. By Type - Global Biomarker Testing for Cancer Sales (K Units), 2023-2028
Table 16. By Application ? Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biomarker Testing for Cancer Sales (K Units), 2017-2022
Table 20. By Application - Global Biomarker Testing for Cancer Sales (K Units), 2023-2028
Table 21. By Region ? Global Biomarker Testing for Cancer Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biomarker Testing for Cancer Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biomarker Testing for Cancer Sales (K Units), 2017-2022
Table 25. By Region - Global Biomarker Testing for Cancer Sales (K Units), 2023-2028
Table 26. By Country - North America Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biomarker Testing for Cancer Sales, (K Units), 2017-2022
Table 29. By Country - North America Biomarker Testing for Cancer Sales, (K Units), 2023-2028
Table 30. By Country - Europe Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biomarker Testing for Cancer Sales, (K Units), 2017-2022
Table 33. By Country - Europe Biomarker Testing for Cancer Sales, (K Units), 2023-2028
Table 34. By Region - Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biomarker Testing for Cancer Sales, (K Units), 2017-2022
Table 37. By Region - Asia Biomarker Testing for Cancer Sales, (K Units), 2023-2028
Table 38. By Country - South America Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biomarker Testing for Cancer Sales, (K Units), 2017-2022
Table 41. By Country - South America Biomarker Testing for Cancer Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biomarker Testing for Cancer Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Biomarker Testing for Cancer Sales, (K Units), 2023-2028
Table 46. F. Hoffmann-L A Roche Corporate Summary
Table 47. F. Hoffmann-L A Roche Biomarker Testing for Cancer Product Offerings
Table 48. F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Thermo Fisher Scientific Corporate Summary
Table 50. Thermo Fisher Scientific Biomarker Testing for Cancer Product Offerings
Table 51. Thermo Fisher Scientific Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Qiagen N.V. Corporate Summary
Table 53. Qiagen N.V. Biomarker Testing for Cancer Product Offerings
Table 54. Qiagen N.V. Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Bio-Rad L aboratories Corporate Summary
Table 56. Bio-Rad L aboratories Biomarker Testing for Cancer Product Offerings
Table 57. Bio-Rad L aboratories Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. llumina Corporate Summary
Table 59. llumina Biomarker Testing for Cancer Product Offerings
Table 60. llumina Biomarker Testing for Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Biomarker Testing for Cancer Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Biomarker Testing for Cancer Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Biomarker Testing for Cancer Production by Region, 2017-2022 (K Units)
Table 64. Global Biomarker Testing for Cancer Production by Region, 2023-2028 (K Units)
Table 65. Biomarker Testing for Cancer Market Opportunities & Trends in Global Market
Table 66. Biomarker Testing for Cancer Market Drivers in Global Market
Table 67. Biomarker Testing for Cancer Market Restraints in Global Market
Table 68. Biomarker Testing for Cancer Raw Materials
Table 69. Biomarker Testing for Cancer Raw Materials Suppliers in Global Market
Table 70. Typical Biomarker Testing for Cancer Downstream
Table 71. Biomarker Testing for Cancer Downstream Clients in Global Market
Table 72. Biomarker Testing for Cancer Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biomarker Testing for Cancer Segment by Type
Figure 2. Biomarker Testing for Cancer Segment by Application
Figure 3. Global Biomarker Testing for Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biomarker Testing for Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biomarker Testing for Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. Biomarker Testing for Cancer Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biomarker Testing for Cancer Revenue in 2021
Figure 9. By Type - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 10. By Type - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biomarker Testing for Cancer Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 13. By Application - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biomarker Testing for Cancer Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 16. By Region - Global Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 19. US Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 24. Germany Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. France Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 33. China Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. India Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 40. Brazil Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biomarker Testing for Cancer Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biomarker Testing for Cancer Sales Market Share, 2017-2028
Figure 44. Turkey Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biomarker Testing for Cancer Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biomarker Testing for Cancer Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Biomarker Testing for Cancer by Region, 2021 VS 2028
Figure 50. Biomarker Testing for Cancer Industry Value Chain
Figure 51. Marketing Channels
